“Endocrinology Drugs Market: Global Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth and Forecast, 2023-2028” provides a deep and thorough evaluation of the endocrinology drugs market by type (diabetes drugs, human growth hormones, testosterone replacement therapy, and thyroid hormone disorder drugs); by application (drugstore, hospital, others); and by geography (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa). Endocrinology drugs are used to treat complications of the endocrine system and regulate the hormonal activities in the body. They are especially targeted towards endocrine organs, including pituitary, thyroid, adrenals, ovaries, testes, and pancreas, that control hormone secretions. They are widely prescribed by healthcare professionals to treat various health conditions, such as Addison’s disease, Cushing’s syndrome, polycystic ovary syndrome (PCOS), diabetes, hypertension, hyperlipidemia, thyroiditis, and osteomalacia.
The global market is primarily driven by the rising incidences of endocrine disorders among the masses, especially in the aging population. Moreover, continual advancements in drug discovery and extensive research and development (R&D) activities conducted by industry players to launch effective endocrinology drugs are expected to propel the market growth.
Segmentation by Type:
Segmentation by Application:
Segmentation by Region:
Competitive Landscape:
The price margins for the products along with the various success and risk factors for manufacturers have also been covered in the report. Moreover, in order to determine market attractiveness, the report analyses the endocrinology drugs industry along the parameters of the porter’s five forces model. This model examines the degree of competition in the endocrinology drugs industry by analysing the threat posed by new entrants and substitutes, and the bargaining power of suppliers and buyers. Swot analysis of the market has also been presented in the report which highlights the strengths, weaknesses, opportunities and threats pertaining to the endocrinology drugs industry. Furthermore, the value chain analysis of the endocrinology drugs industry has also been covered in the report. This comprises of all the activities in the value chain, such as the procurement of various raw materials, manufacturing and sales of the products, and their distribution.
Highlights of the Endocrinology Drugs Market
The report is a result of exhaustive primary and secondary research undertaken by analysts having years of experience in the endocrinology drugs industry. All the qualitative and quantitative aspects of the industry have been covered and the collected data has been analysed and presented in the form of easily comprehensible charts, graphs and tables.
1 Introduction
1.1 Research Objectives
1.2 Stakeholders
1.3 Scope of the Report
1.4 Assumptions and Limitations
2. Research Methodology
2.1. Data Collection
2.1.1 Primary Sources
2.1.2 Secondary Sources
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Data Validation
3. Executive Summary
4. Global Endocrinology Drugs Market
4.1 Industry Overview
4.2 Key Industry Developments
4.3 Market Trends
4.3.1 Key Market Indicators
4.3.2 Historical Market Trends
4.3.3 Market Forecast
4.4 Price Analysis
4.4.1 Key Price Indicators
4.4.2 Pricing Structure
4.4.3 Historical Price Trends
4.4.4 Price Forecast
4.5 Market Breakup By Region
4.6 Market Breakup By Type
4.7 Market Breakup By Application
5. Global Endocrinology Drugs Market: Value Chain Analysis
5.1 Overview
5.2 Research and Development
5.3 Raw Material Suppliers
5.4 Inbound Logistics
5.5 Production
5.6 Marketing
5.7 Outbound Logistics
5.8 Consumers
6. Global Endocrinology Drugs Market: SWOT Analysis
6.1 Overview
6.2 Strengths
6.3 Weaknesses
6.4 Opportunities
6.5 Threats
7. Global Endocrinology Drugs Market: Porter’s Five Forces Analysis
7.1 Overview
7.2 Threat of New Entrants
7.3 Threat of Substitutes
7.4 Bargaining Power of Buyers
7.5 Bargaining Power of Suppliers
7.6 Intensity of Rivalry
8. Competitive Landscape
8.1 Market Structure
8.2 Key Players
8.3 Key Success Factors
9. Performance By Region
9.1 North America
9.1.1 Overview
9.1.2 Market Trends
9.1.3 Market Segmentation
9.1.4 Market Forecast
9.2 Europe
9.2.1 Overview
9.2.2 Market Trends
9.2.3 Market Segmentation
9.2.4 Market Forecast
9.3 Asia Pacific
9.3.1 Overview
9.3.2 Market Trends
9.3.3 Market Segmentation
9.3.4 Market Forecast
9.4 Latin America
9.4.1 Overview
9.4.2 Market Trends
9.4.3 Market Segmentation
9.4.4 Market Forecast
9.5 Middle East and Africa
9.5.1 Overview
9.5.2 Market Trends
9.5.3 Market Segmentation
9.5.4 Market Forecast
10 Key Player Profiles
List of Figures
Figure 1: Global: Endocrinology Drugs Market, 2017-2022
Figure 2: Global: Endocrinology Drugs Market Forecast, 2023-2028
Figure 3: Global: Endocrinology Drugs Market: Price Trends, 2017-2022
Figure 4: Global: Endocrinology Drugs Market Forecast: Price Trends, 2023-2028
Figure 5: Global: Endocrinology Drugs Market: Breakup by Region, 2022
Figure 6: Global: Endocrinology Drugs Market: Breakup by Type, 2022
Figure 7: Global: Endocrinology Drugs Market: Breakup by End Use, 2022
Figure 8: Global: Endocrinology Drugs Industry: Value Chain Analysis
Figure 9: Global: Endocrinology Drugs Industry: SWOT Analysis
Figure 10: Global: Endocrinology Drugs Industry: Porter’s Five Forces Analysis
Figure 11: Global: Endocrinology Drugs Market: Key Players
Figure 12: North America: Endocrinology Drugs Market, 2017-2022
Figure 13: North America: Endocrinology Drugs Market: Breakup by Segment, 2022
Figure 14: North America: Endocrinology Drugs Market Forecast, 2023-2028
Figure 15: Europe: Endocrinology Drugs Market, 2017-2022
Figure 16: Europe: Endocrinology Drugs Market: Breakup by Segment, 2022
Figure 17: Europe: Endocrinology Drugs Market Forecast, 2023-2028
Figure 18: Asia Pacific: Endocrinology Drugs Market, 2017-2022
Figure 19: Asia Pacific: Endocrinology Drugs Market: Breakup by Segment, 2022
Figure 20: Asia Pacific: Endocrinology Drugs Market Forecast, 2023-2028
Figure 21: Latin America: Endocrinology Drugs Market, 2017-2022
Figure 22: Latin America: Endocrinology Drugs Market: Breakup by Segment, 2022
Figure 23: Latin America: Endocrinology Drugs Market Forecast, 2023-2028
Figure 24: Middle East and Africa: Endocrinology Drugs Market, 2017-2022
Figure 25: Middle East and Africa: Endocrinology Drugs Market: Breakup by Segment, 2020
Figure 26: Middle East and Africa: Endocrinology Drugs Market Forecast, 2023-2028
List of Tables
Table 1: Global: Endocrinology Drugs Industry: Market Summary
Table 2: Global: Endocrinology Drugs Industry: Market Overview, 2022 and 2028
Table 3: Global: Endocrinology Drugs Industry: Market Structure
Table 4: Global: Endocrinology Drugs Market: Market by Region, 2023-2028
Personalize this research
Triangulate with your own data
Get data as per your format and definition
Gain a deeper dive on a specific application, geography, customer or competitor
Any level of personalization
US: +1-213-316-7435
Uk: +44-702-409-7740
sales@syndicatedanalytics.com
The GCC Weight Management Market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. The market is projected to register a CAGR of X% during 2023-2028, reaching US$ XX Billion by 2028.
Read More The GCC orthopedic braces and supports market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028.
Read MoreThe GCC generic drug market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028.
Read MoreThe GCC telemedicine market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028.
Read MoreThe UAE mhealth market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028.
Read MoreThe Saudi Arabia health insurance market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028.
Read More+1-213-316-7435
us.sales@syndicatedanalytics.com
+44-702-409-7740
uk.sales@syndicatedanalytics.com
© Copyright Syndicated Analytics 2023.